Related Experiment Videos
[Development of anti cancer drugs targeted on Fas-mediated apoptosis signal]
1Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd.
Abstract:
The elimination of tumor cells by cytotoxic T lymphocytes (CTLs) is, in part, executed by inducing apoptosis through the cell surface antigen Fas on the target cells. There are many cancer cells that resist Fas-mediated apoptosis. To elucidate the mechanism of this resistance is very important to understand the process of tumor development. We focused on FAP-1 (Fas-associated phos phatase-1), a negative regulator of Fas-mediated apoptosis. The expression of FAP-1 was detected in many colon cancer cell lines. On the other hand no FAP-1 expression was detected in the normal colon tissue. We have found that the tri-peptide of Fas C-terminus inhibited the binding of Fas and FAP-1 in vitro. Microinjection of the tri peptide (Ac SLV) could induce Fas-mediated apoptosis in the DLD 1 human colon cancer cell line that was resistant to anti-Fas-antibody. These findings suggest that the interaction of Fas and FAP-1 has a very important role in Fas-mediated apoptosis signal transduction. The inhibition of the Fas/ FAP-1 binding will provide a good target to develop anti-cancer drugs.
Insights
Cancer cells resist T cell-induced apoptosis via Fas-associated phosphatase-1 (FAP-1). Inhibiting the Fas/FAP-1 interaction with a tri-peptide drug can overcome this resistance, offering a new anti-cancer therapy target.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Cytotoxic T lymphocytes (CTLs) eliminate tumor cells by inducing apoptosis via the Fas receptor.
- Many cancer cells exhibit resistance to Fas-mediated apoptosis, hindering effective anti-tumor immunity.
- Fas-associated phosphatase-1 (FAP-1) acts as a negative regulator of Fas-mediated apoptosis.
Purpose of the Study:
- To investigate the role of FAP-1 in Fas-mediated apoptosis resistance in colon cancer.
- To identify potential therapeutic strategies targeting the Fas/FAP-1 interaction.
Main Methods:
- Detection of FAP-1 expression in colon cancer cell lines and normal colon tissue.
- In vitro assessment of a Fas C-terminus tri-peptide's ability to inhibit Fas/FAP-1 binding.
- Microinjection of the tri-peptide (Ac-SLV) into resistant colon cancer cells to induce apoptosis.
Main Results:
- FAP-1 was expressed in colon cancer cell lines but not in normal colon tissue.
- The Fas C-terminus tri-peptide effectively inhibited Fas/FAP-1 binding in vitro.
- Microinjection of Ac-SLV induced Fas-mediated apoptosis in Fas-resistant DLD-1 colon cancer cells.
Conclusions:
- The interaction between Fas and FAP-1 is crucial for regulating Fas-mediated apoptosis signal transduction.
- FAP-1 expression contributes to resistance against Fas-mediated apoptosis in colon cancer.
- Inhibiting the Fas/FAP-1 interaction presents a promising therapeutic target for developing novel anti-cancer drugs.